| Literature DB >> 28033399 |
Sanja Schreiber1, Eric C Parent2, Elham Khodayari Moez3, Douglas M Hedden4,5, Douglas L Hill4,5, Marc Moreau4,5, Edmond Lou4,6, Elise M Watkins1, Sarah C Southon4,5.
Abstract
BACKGROUND: The North American non-surgical standard of care for adolescent idiopathic scoliosis (AIS) includes observation and bracing, but not exercises. Schroth physiotherapeutic scoliosis-specific exercises (PSSE) showed promise in several studies of suboptimal methodology. The Scoliosis Research Society calls for rigorous studies supporting the role of exercises before including it as a treatment recommendation for scoliosis.Entities:
Mesh:
Year: 2016 PMID: 28033399 PMCID: PMC5198985 DOI: 10.1371/journal.pone.0168746
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Fig 1CONSORT flow diagram.
Baseline characteristics of the study population.
| Schroth exercises + Standard of care (95% Confidence interval), N = 25 | Standard of care (95% Confidence interval), N = 25 | |
|---|---|---|
| 13.5 (12.7–14.2) | 13.3 (12.7–13.9) | |
| 23 (92) | 24 (96) | |
| 17 (68) | 17 (68) | |
| 1.60 (1.6–1.6) | 1.60 (1.6–1.6) | |
| 45.9 (42.6–49.1) | 50.5 (47.1–54.0) | |
| 29.1 (25.4–32.8) | 27.9 (24.3–31.5) | |
| 48.1 (39.1–57.2) | 54.3 (44.9–63.6) | |
| 1.76 (1.10 to 2.45) | 1.44 (0.77 to 2.11) | |
| 65 | 65 |
Raw mean scores for each outcome at baseline and 6-month follow-up.
“0”—Standard of care group; “1”—“Schroth + standard of care group.
| Outcome | Group | Number of patients | Mean | Standard Deviation | 95% Confidence Interval | Minimum | Maximum |
|---|---|---|---|---|---|---|---|
| 0 | 25 | 27.9 | 8.8 | 24.3–31.5 | 11.7 | 42.0 | |
| 1 | 25 | 29.1 | 8.9 | 25.4–32.8 | 11.3 | 44.3 | |
| Total | 50 | 28.5 | 8.8 | 26.0–31.0 | 11.3 | 44.3 | |
| 0 | 25 | 54.3 | 22.6 | 44.9–63.6 | 11.7 | 95.1 | |
| 1 | 25 | 48.2 | 21.9 | 39.1–57.2 | 11.3 | 86.0 | |
| Total | 50 | 51.2 | 22.3 | 44.9–57.5 | 11.3 | 95.1 | |
| 0 | 20 | 29.1 | 8.8 | 25.0–33.3 | 12.1 | 44.7 | |
| 1 | 23 | 27.7 | 8.9 | 23.8–31.5 | 14.4 | 43.9 | |
| Total | 43 | 28.4 | 8.8 | 25.7–31.0 | 12.1 | 44.7 | |
| 0 | 20 | 57.5 | 24.9 | 45.8–69.1 | 15.8 | 102.4 | |
| 1 | 23 | 45.7 | 21.4 | 36.4–54.9 | 14.4 | 80.6 | |
| Total | 43 | 51.2 | 23.6 | 43.9–58.4 | 14.4 | 102.4 |
Linear mixed effects model coefficients and significance values in the intention-to-treat and the per protocol analyses with 95% confidence intervals;.
| Intention to treat (N = 50) | Per protocol (N = 44) | |||||
|---|---|---|---|---|---|---|
| Value | 95% Confidence interval | p-value | Value | 95% Confidence interval | p-value | |
| - 3.53 | -5.94 to -1.12 | -4.13 | -6.51 to -1.74 | |||
| 6.87 | 1.38 to 12.36 | 9.00 | 3.47 to 14.52 | |||
| 2.32 | 0.56 to 4.08 | 2.31 | 0.62 to 4.00 | |||
| - 31.88 | -65.28 to 7.86 | 0.13 | -31.88 | -70.14 to 6.38 | 0.11 | |
| 0.44 | 0.04 to 0.82 | 0.50 | 0.11 to 0.89 | |||
| 12.14 | 5.51 to 18.86 | 12.36 | 5.36 to 19.36 | |||
| 1.76 | -8.41 to 9.11 | 0.69 | 0.35 | -8.41 to 9.11 | 0.94 | |
| 8.29 | 2.98 to 14.90 | 8.25 | 1.47 to 15.03 | |||
| - 0.40 | -0.77 to -0.03 | - 0.50 | -0.84 to -0.16 | |||
| 0.48 | -1.44 to 2.40 | 0.33 | 0.83 | -0.11 to 1.77 | 0.09 | |
| 0.27 | 0.0 to 0.54 | 0.07 | 0.25 | 0.01 to 0.49 | ||
| - 5.09 | -1.63 to 11.81 | 0.14 | -5.77 | -12.90 to 1.36 | 0.12 | |
| 0.10 | 0.02 to 0.18 | 0.10 | 0.02 to 0.17 | |||
| 1.49 | 0.27 to 2.70 | 1.14 | -0.15 to 2.43 | 0.09 | ||
| -1.17 | -2.74 to 0.40 | 0.15 | -1.69 | -3.32 to -0.06 | 0.05 | |
| 0.24 | -0.92 to 1.40 | 0.69 | -0.04 | -1.31 to 1.23 | 0.95 | |
* Using Holm-Bonferroni sequential correction all of our calculated p-values remained significant.
Number of patients with improved, deteriorated and stable curves using a 5° Cobb angle clinical significance threshold.
| Schroth + standard of care | Standard of care | |
|---|---|---|
| 3 (12) | 10 (40) | |
| 4 (16) | 1 (4) | |
| 18 (72) | 14 (56) |